top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antisense RNA Design, Delivery, and Analysis / / edited by Virginia Arechavala-Gomeza, Alejandro Garanto
Antisense RNA Design, Delivery, and Analysis / / edited by Virginia Arechavala-Gomeza, Alejandro Garanto
Autore Arechavala-Gomeza Virginia
Edizione [1st ed. 2022.]
Pubbl/distr/stampa New York, : Springer Nature, 2022
Descrizione fisica 1 online resource (XVII, 422 p. 69 illus., 59 illus. in color.)
Disciplina 615.5
Collana Methods in Molecular Biology
Soggetto topico Therapeutics
Biomaterials
Nucleic acids
Nucleic Acid
ISBN 9781071620106
107162010X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Introduction and History of the Chemistry of Nucleic Acids Therapeutics -- Antisense RNA Therapeutics: A Brief Overview -- Design of Bifunctional Antisense Oligonucleotides for Exon Inclusion -- Design and Delivery of SINEUP: A New Modular Tool to Increase Protein Translation -- How to Design U1 snRNA Molecules for Splicing Rescue -- Conjugation of Nucleic Acids and Drugs to Gold Nanoparticles -- Determination of Optimum Ratio of Cationic Polymers and Small Interfering RNA with Agarose Gel Retardation Assay -- Generation of Protein-Phosphorodiamidate Morpholino Oligomer Conjugates for Efficient Cellular Delivery via Anthrax Protective Antigen -- Development and Use of Cellular Systems to Assess and Correct Splicing Defects -- Modeling Splicing Variants Amenable to Antisense Therapy by Use of CRISPR-Cas9-Based Gene Editing in HepG2 Cells -- In Vitro Models for the Evaluation of Antisense Oligonucleotides in Skin -- In Vitro Delivery of PMOs in Myoblasts by Electroporation -- Rapid Determination of MBNL1 Protein Levels by Quantitative Dot Blot for Evaluation of Antisense Oligonucleotides in Myotonic Dystrophy Myoblasts -- Evaluation of Exon Skipping and Dystrophin Restoration in In Vitro Models of Duchenne Muscular Dystrophy -- Generation of Human iPSC-Derived Myotubes to Investigate RNA-Based Therapies In Vitro -- Eye on a Dish Models to Evaluate Splicing Modulation -- Establishment of In Vitro Brain Models for AON Delivery -- Considerations for Generating Humanized Mouse Models to Test Efficacy of Antisense Oligonucleotides -- Generation of Humanized Zebrafish Models for the In Vivo Assessment of Antisense Oligonucleotide-Based Splice Modulation Therapies -- Use of Small Animal Models for Duchenne and Parameters to Assess Efficiency upon Antisense Treatment -- In Vivo Models for the Evaluation of Antisense Oligonucleotides in Skin -- Delivery of Antisense Oligonucleotides to the Mouse Retina -- Delivery of Antisense Oligonucleotides to the Mouse Brain by Intracerebroventricular Injections -- Intrathecal Delivery of Therapeutic Oligonucleotides for Potent Modulation of Gene Expression in the Central Nervous System -- Preclinical Safety Assessment of Therapeutic Oligonucleotides -- Preclinical Evaluation of the Renal Toxicity of Oligonucleotide Therapeutics in Mice -- Protocol for Isolation and Culture of Mouse Hepatocytes (HCs), Kupffer Cells (KCs), and Liver Sinusoidal Endothelial Cells (LSECs) in Analyses of Hepatic Drug Distribution -- Patent Considerations When Embarking on New Antisense Drug Programs.
Record Nr. UNINA-9910552988503321
Arechavala-Gomeza Virginia  
New York, : Springer Nature, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Therapies for Inherited Retinal Diseases
Molecular Therapies for Inherited Retinal Diseases
Autore Collin Rob W.J
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (262 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato AAV
ABCA4
adeno-associated viral
adeno-associated virus (AAV)
allele-specific knockdown
antisense oligonucleotides
AON-mediated exon skipping
apical polarity
apoptosis
ARPE-19 cells
autophagy
autosomal dominant
bipolar cells
CEP290
chaperones
chaperonins
choroideremia
Cilia elongation
clathrin-coated vesicles
clinical trials
clustered regularly interspaced short palindromic repeats (CRISPR)
compound therapies
cones
crumbs complex
cyclic GMP
DNA therapies
DNA-wrapped gold nanoparticles
drug delivery systems
dual AAV
endosomal trafficking
Enhanced S-Cone Syndrome (ESCS)
fetal retina
Flanders founder c.4723A >
G56R
gapmer antisense oligonucleotides
gene augmentation
gene therapy
gold nanoparticles
heat shock response
homology-directed repair (HDR)
induced pluripotent stem cell (iPSC)
inherited retinal disease
inherited retinal diseases
iPSC-derived photoreceptor precursor cells
IRD
Leber congenital amaurosis
Leber congenital amaurosis and allied retinal ciliopathies
microRNA
Müller glia
n/a
necrosis
nonprofit
NR2E3
PAR complex
patient registry
photoreceptors
protein degradation
protein folding
protein trafficking
putative dominant negative effect
REP1
retina
retinal degeneration
retinal inherited disorders
retinal organoids
retinal pigment epithelium
retinitis pigmentosa
Retinitis Pigmentosa (RP)
Retinitis Pigmentosa GTPase Regulator
retinogenesis
RNA therapies
RNA therapy
rods
RPE65
splicing modulation
spontaneous nonsense correction
Stargardt disease
T nonsense mutation
therapy
translational
translational medicine
treatment
unfolded protein response
Usher syndrome
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910674051103321
Collin Rob W.J  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui